Uremia-associated immune defect: The IL-10-CRP axis

Kidney International, Supplement

Volumn 63, Issue 84, 2003, Pages

  Girndt, Matthias ^a   Ulrich, Christof ^a   Kaul, Harald ^a   Sester, Urban ^a   Sester, Martina ^a   Köhler, Hans ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Atherosclerosis; Chronic kidney failure; Hemodialysis; Interleukin 10

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CONFERENCE PAPER; CYTOKINE RELEASE; DIALYSIS; HUMAN; IMMUNE DEFICIENCY; INFLAMMATION; KIDNEY FAILURE; MACROPHAGE; MONOCYTE; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; UREMIA; CHRONIC KIDNEY FAILURE; IMMUNOLOGY; REVIEW;

C-REACTIVE PROTEIN; HUMANS; INTERLEUKIN-10; KIDNEY FAILURE, CHRONIC; UREMIA;

EID: 0037407291     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.63.s84.14.x     Document Type: Conference Paper

References (19)

1. GIRNDT M, SESTER U, KAUL H, KÖHLER H: Production of proinflammatory and regulatory monokines in hemodialysis patients shown at a single cell level. J Am Soc Nephrol 9:1689-1696, 1998
2. ROSS R: Atherosclerosis - an inflammatory disease. N Engl J Med 340:115-126, 1999
3. SCHIEFFER B, SCHIEFFER E, HILFIKER-KLEINER D, et al: Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: Potential implications for inflammation and plaque instability. Circulation 101:1372-1378, 2000
4. GOTTSÄTER A, FORSBLAD J, MATZSCH T, et al: Interleukin-1 receptor antagonist is detectable in human carotid artery plaques and is related to triglyceride levels and Chlamydia pneumoniae IgA antibodies. J Intern Med 251:61-68, 2002
5. KIECHL S, EGGER G, MAYR M, et al: Chronic infections and the risk of carotid atherosclerosis: Prospective results from a large population study. Circulation 103:1064-1070, 2001
6. MOORE KW, O'GARRA A, DE WAAL MALEFYT R, et al: Interleukin-10. Annu Rev Immunol 11:165-190, 1993
7. GIRNDT M, KÖHLER H, SCHIEDHELM WEICK E, et al: Production of interleukin-6, tumor necrosis factor alpha and interleukin-10 in vitro correlates with the clinical immune defect in chronic hemodialysis patients. Kidney Int 47:559-565, 1995
8. MORITA Y, YAMAMURA M, KASHIHARA N, MAKING H: Increased production of interleukin-10 and inflammatory cytokines in blood monocytes of hemodialysis patients. Res Commun Mol Pathol Pharmacol 98:19-33, 1997
9. MALLAT Z, BESNARD S, DURIEZ M, et al: Protective role of interleukin-10 in atherosclerosis. Circ Res 85:e17-e24, 1999
10. RAISANEN-SOKOLOWSKI A, GLYSING-JENSEN T, RUSSELL ME: Leukocyte-suppressing influences of interleukin (IL)-10 in cardiac allografts: insights from IL-10 knockout mice. Am J Pathol 153:1491-1500, 1998
11. VON DER THÜSEN JH, KUIPER J, FEKKES ML, et al: Attenuation of atherogenesis by systemic and local adenovirus-mediated gene transfer of interleukin-10 in LDLr-/- mice. FASEB J 15:2730-2732, 2001
12. SMITH DA, IRVING SD, SHELDON J, et al: Serum levels of the anti-inflammatory cytokine interleukin-10 are decreased in patients with unstable angina. Circulation 104:746-749, 2001
13. TURNER DM, WILLIAMS DM, SANKARAN D, et al: An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogen 24:1-8, 1997
14. GIRNDT M, SESTER U, SESTER M, et al: The interleukin-10 promoter genotype determines clinical immune function in hemodialysis patients. Kidney Int 60:2385-2391, 2001
15. GIRNDT M, KAUL H, SESTER U, et al: Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int 62:949-955, 2002
16. RIDKER PM, CUSHMAN M, STAMPFER MJ, et al: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979, 1997
17. DONGER C, GEORGES JL, NICAUD V, et al: New polymorphisms in the interleukin-10 gene-relationships to myocardial infarction. Eur J Clin Invest 31:9-14, 2001
18. KOCH W, KASTRATI A, BOTTIGER C, et al: Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 159:137-144, 2001
19. RIDKER PM, RIFAI N, CLEARFIELD M, et al: Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 344:1959-1965, 2001